Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake

Journal of Hepatology

Volumn 54, Issue 4, 2011, Pages 705-715

  Lambert, Marie Pierre ^a   Paliwal, Anupam ^a   Vaissière, Thomas ^a   Chemin, Isabelle ^b   Zoulim, Fabien ^b   Tommasino, Massimo ^a   Hainaut, Pierre ^a   Sylla, Bakary ^a   Scoazec, Jean Yves ^c   Tost, Jörg ^d   Herceg, Zdenko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b INSERM   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d CENTRE NATIONAL DE GÉNOTYPAGE   (France)

Author keywords

Alcohol intake; Cirrhosis; Concurrent hypermethylation; DNA methylation; HBV infection; HCV infection; Hepatocellular carcinoma

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; DOCKING PROTEIN; DOCKING PROTEIN 1; GLUTATHIONE TRANSFERASE P1; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA3; NICOTINIC RECEPTOR; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE SILENCING; GEOGRAPHY; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PYROSEQUENCING; QUANTITATIVE ANALYSIS; RISK FACTOR;

ADULT; AGED; ALCOHOL DRINKING; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; DNA METHYLATION; DNA PRIMERS; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; GENE SILENCING; GLUTATHIONE S-TRANSFERASE PI; HEPATITIS B; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PHOSPHOPROTEINS; RECEPTORS, NICOTINIC; RISK FACTORS; RNA-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 79952705527     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.07.027     Document Type: Article

References (49)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37 (Suppl. 8):S4-66.
2. Hamilton SR, Aaltonen LA. Pathology and genetics of tumours of the digestive system - pathology and pathogenesis of hepatocellular carcinoma. IARC Press; 2000.
3. Montesano R, Hainaut P, Wild CP. Hepatocellular carcinoma: from gene to public health. J Natl Cancer Inst 1997;89 (24):1844-1851. (Pubitemid 28009820)
4. Feitelson MA. Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma. Cancer Lett 2006;239 (1):10-20. (Pubitemid 43949592)
5. Paterlini-Brechot P, Saigo K, Murakami Y, Chami M, Gozuacik D, Mugnier C, et al. Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene 2003;22 (25):3911-3916. (Pubitemid 36819664)
6. Laurent-Puig P, Zucman-Rossi J. Genetics of hepatocellular tumors. Oncogene 2006;25 (27):3778-3786. (Pubitemid 43980473)
7. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003;33 (Suppl. 1):245-254. (Pubitemid 36278835)
8. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002;16 (1):6-21. (Pubitemid 34049633)
9. Herceg Z. Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis 2007;22 (2):91-103. (Pubitemid 46364521)
10. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev 2002;3 (6):415-428. (Pubitemid 34587077)
11. Shen L, Ahuja N, Shen Y, Habib NA, Toyota M, Rashid A, et al. DNA methylation and environmental exposures in human hepatocellular carcinoma. J Natl Cancer Inst 2002;94 (10):755-761. (Pubitemid 34567960)
12. Gao W, Kondo Y, Shen L, Shimizu Y, Sano T, Yamao K, et al. Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas. Carcinogenesis 2008;29 (10):1901-1910.
13. Kondo Y, Kanai Y, Sakamoto M, Mizokami M, Ueda R, Hirohashi S. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis - a comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology (Baltimore, Md) 2000;32 (5):970-979.
14. Su PF, Lee TC, Lin PJ, Lee PH, Jeng YM, Chen CH, et al. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma. Int J cancer 2007;121 (6):1257-1264.
15. Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ, Kang GH. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am J Pathol 2003;163 (4):1371-1378. (Pubitemid 37175085)
16. Zhang YJ, Rossner Jr P, Chen Y, Agrawal M, Wang Q, Wang L, et al. Aflatoxin B1 and polycyclic aromatic hydrocarbon adducts, p53 mutations and p16 methylation in liver tissue and plasma of hepatocellular carcinoma patients. Int J cancer 2006;119 (5):985-991. (Pubitemid 44116904)
17. Roncalli M, Bianchi P, Bruni B, Laghi L, Destro A, Di Gioia S, et al. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma. Hepatology (Baltimore, Md) 2002;36 (2):427-432. (Pubitemid 34810363)
18. Hernandez-Vargas H, Lambert MP, Le Calvez-Kelm F, Gouysse G, McKay-Chopin S, Tavtigian SV, et al. Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors. PLoS One 2010;5 (3):e9749.
19. Nishida N, Nagasaka T, Nishimura T, Ikai I, Boland CR, Goel A. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology (Baltimore, Md) 2008;47 (3):908-918. (Pubitemid 351449682)
20. Edamoto Y, Hara A, Biernat W, Terracciano L, Cathomas G, Riehle HM, et al. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis. Int J Cancer 2003;106 (3):334-341. (Pubitemid 36870393)
21. Vaissiere T, Hung RJ, Zaridze D, Moukeria A, Cuenin C, Fasolo V, et al. Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res 2009;69 (1):243-252.
22. Tost J, Dunker J, Gut IG. Analysis and quantification of multiple methylation variable positions in CpG islands by pyrosequencing. BioTechniques 2003;35 (1):152-156. (Pubitemid 36828725)
23. Colella S, Shen L, Baggerly KA, Issa JP, Krahe R. Sensitive and quantitative universal pyrosequencing methylation analysis of CpG sites. BioTechniques 2003;35 (1):146-150. (Pubitemid 36828724)
24. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004;32 (3):e38.
25. Bock CT, Schranz P, Schroder CH, Zentgraf H. Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell. Virus Genes 1994;8 (3):215-229. (Pubitemid 24239779)
26. Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 2005;5 (3):223-231. (Pubitemid 40314953)
27. Chalitchagorn K, Shuangshoti S, Hourpai N, Kongruttanachok N, Tangkijvanich P, Thong-ngam D, et al. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 2004;23 (54):8841-8846. (Pubitemid 39593298)
28. Estecio MR, Gharibyan V, Shen L, Ibrahim AE, Doshi K, He R, et al. LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS One 2007;2 (5):e399.
29. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007;128 (4):683-692. (Pubitemid 46273572)
30. Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999;21 (1):103-107. (Pubitemid 29036293)
31. Pfeifer GP, Dammann R. Methylation of the tumor suppressor gene RASSF1A in human tumors. Biochemistry 2005;70 (5):576-583. (Pubitemid 40920802)
32. Lee S, Roy F, Galmarini CM, Accardi R, Michelon J, Viller A, et al. Frameshift mutation in the DOK1 gene in chronic lymphocytic leukemia. Oncogene 2004;23 (13):2287-2297. (Pubitemid 38496783)
33. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008;452 (7187):633-637. (Pubitemid 351483367)
34. Schuller HM. Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat Rev Cancer 2009;9 (3):195-205.
35. Paliwal A, Vaissiere T, Krais A, Cuenin C, Cros MP, Zaridze D, et al. Aberrant DNA methylation links cancer susceptibility locus 15q25.1 to apoptotic regulation and lung cancer. Cancer Res 2010;70 (7):2779-2788.
36. Belinsky SA. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 2004;4 (9):707-717. (Pubitemid 39215069)
37. Gil J, Peters G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 2006;7 (9):667-677. (Pubitemid 44268212)
38. Jacinto FV, Esteller M. MGMT hypermethylation: a prognostic foe, a predictive friend. DNA Repair 2007;6 (8):1155-1160. (Pubitemid 47058396)
39. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001;61 (8):3225-3229. (Pubitemid 32695003)
40. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 1999;59 (1):67-70. (Pubitemid 29062958)
41. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994;7 (4):536-540. (Pubitemid 24308343)
42. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999;96 (15):8681-8686. (Pubitemid 29354851)
43. Issa JP. Aging, DNA methylation and cancer. Crit Rev Oncol/Hematol 1999;32 (1):31-43.
44. Issa JP. The epigenetics of colorectal cancer. Ann NY Acad Sci 2000;910:140-153, discussion 153-145.
45. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 1998;58 (23):5489-5494. (Pubitemid 28551135)
46. Anzola M. Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis. J Viral Hepat 2004;11 (5):383-393. (Pubitemid 39336219)
47. van Engeland M, Weijenberg MP, Roemen GM, Brink M, de Bruine AP, Goldbohm RA, et al. Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. Cancer Res 2003;63 (12):3133-3137. (Pubitemid 36735864)
48. Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC. Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 1995;87 (4):265-273.
49. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004;4 (12):988-993.